NASDAQ:BRKR - Bruker Stock Price, Price Target & More

$30.63 -0.03 (-0.10 %)

(As of 04/23/2018 04:00 PM ET)

Previous Close$30.66

Today's Range$30.52 - $31.74

52-Week Range$22.21 - $36.53

Volume868,896 shs

Average Volume571,069 shs

Market Capitalization$4.79 billion

P/E Ratio25.70

Dividend Yield0.53%

Beta1.12

About Bruker (NASDAQ:BRKR)

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide. The company operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear and explosive detection in emergency response, homeland security, and defense applications; and analytical and process analysis instruments and solutions. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and various other representatives. The company has an agreement with Evosep One for the co-development of the Evosep One chromatography system. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments

Sub-IndustryLife Sciences Tools & Services

SectorComputer and Technology

SymbolNASDAQ:BRKR

CUSIP11679410

Webwww.bruker.com

Phone978-663-3660

Debt

Debt-to-Equity Ratio0.57%

Current Ratio2.59%

Quick Ratio1.66%

Price-To-Earnings

Trailing P/E Ratio25.70

Forward P/E Ratio22.36

P/E Growth2.03

Sales & Book Value

Annual Sales$1.77 billion

Price / Sales2.71

Cash Flow$1.6468 per share

Price / Cash18.60

Book Value$4.72 per share

Price / Book6.49

Profitability

EPS (Most Recent Fiscal Year)$1.21

Net Income$78.60 million

Net Margins4.45%

Return on Equity26.68%

Return on Assets10.33%

Miscellaneous

Employees6,200

Outstanding Shares156,080,000

How to Become a New Pot Stock Millionaire

Bruker (NASDAQ:BRKR) Frequently Asked Questions

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Tuesday, February 20th. Investors of record on Tuesday, March 6th will be paid a dividend of $0.04 per share on Friday, March 23rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend is Monday, March 5th. View Bruker's Dividend History.

How will Bruker's stock buyback program work?

Bruker declared that its Board of Directors has initiated a share repurchase plan on Sunday, June 4th 2017, which permits the company to repurchase $225,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board of directors believes its shares are undervalued.

How were Bruker's earnings last quarter?

Bruker (NASDAQ:BRKR) released its earnings results on Thursday, February, 8th. The medical research company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.02. The medical research company had revenue of $530.50 million for the quarter, compared to analysts' expectations of $506.74 million. Bruker had a net margin of 4.45% and a return on equity of 26.68%. The business's quarterly revenue was up 12.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.46 EPS. View Bruker's Earnings History.

When is Bruker's next earnings date?

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Bruker.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY18 earnings guidance on Thursday, February, 8th. The company provided EPS guidance of $1.34 to $1.38 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.34. The company issued revenue guidance of $1.889 billion, compared to the consensus revenue estimate of $1.82 billion.

What price target have analysts set for BRKR?

14 brokers have issued 1-year target prices for Bruker's stock. Their predictions range from $24.00 to $42.00. On average, they expect Bruker's share price to reach $32.00 in the next twelve months. View Analyst Ratings for Bruker.

Who are some of Bruker's key competitors?

Some companies that are related to Bruker include PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Integra lifesciences (IART), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Pacific Biosciences (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), HTG Molecular Diagnostics (HTGM), pSivida (EYPT) and Precipio (PRPO).

Who are Bruker's key executives?

Bruker's management team includes the folowing people:

Dr. Frank H. Laukien Ph.D., Chairman, Chief Exec. Officer and Pres (Age 58)
Dr. Mark R. Munch Ph.D., Exec. VP, Pres of Bruker Nano Surfaces Division and Pres of Bruker Nano Group (Age 56)
Mr. Anthony L. Mattacchione, Former CFO & Sr. VP (Age 55)
Mr. Juergen Srega, Pres of Bruker Daltonics Division and Pres of Bruker CALID Group (Age 63)
Mr. Gerald N. Herman, Interim CFO & Principal Accounting Officer

Has Bruker been receiving favorable news coverage?

Media headlines about BRKR stock have trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bruker earned a daily sentiment score of 0.17 on Accern's scale. They also assigned news stories about the medical research company an impact score of 47.92 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $30.63.

How big of a company is Bruker?

Bruker has a market capitalization of $4.79 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]

MarketBeat Community Rating for Bruker (BRKR)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		422 (Vote Outperform)
Underperform Votes:		487 (Vote Underperform)
Total Votes:		909

MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Bruker (NASDAQ:BRKR) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

14 Wall Street analysts have issued ratings and price targets for Bruker in the last 12 months. Their average twelve-month price target is $32.00, suggesting that the stock has a possible upside of 4.47%. The high price target for BRKR is $42.00 and the low price target for BRKR is $24.00. There are currently 2 sell ratings, 9 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.07	2.07	2.13	2.08
Ratings Breakdown:	2 Sell Rating(s) 9 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 10 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 9 Hold Rating(s) 4 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 8 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$32.00	$32.0833	$31.8333	$26.00
Price Target Upside:	4.47% upside	6.10% upside	9.02% downside	11.77% downside

Bruker (NASDAQ:BRKR) Consensus Price Target History

Price Target History for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/11/2018	Morgan Stanley	Lower Price Target	Equal Weight -> Equal Weight	$32.00 -> $31.00	Low
2/9/2018	Leerink Swann	Boost Price Target	Market Perform -> Market Perform	$32.00 -> $34.00	High
1/5/2018	BTIG Research	Initiated Coverage	Buy -> Buy	$42.00	High
1/3/2018	Evercore ISI	Initiated Coverage	In-Line	$36.00	Low
12/21/2017	Cowen	Reiterated Rating	Hold	$35.00	Low
11/3/2017	Citigroup	Boost Price Target	Neutral	$29.00 -> $34.00	N/A
11/3/2017	Bank of America	Upgrade	Underperform -> Neutral	$34.00	N/A
11/3/2017	JPMorgan Chase	Upgrade	Underweight -> Neutral	$28.00	N/A
9/26/2017	Goldman Sachs	Reiterated Rating	Sell -> Sell	$24.00	Low
7/17/2017	Barclays	Reiterated Rating	Equal Weight	$26.00 -> $30.00	Low
7/12/2017	Wells Fargo	Downgrade	Market Perform -> Underperform		Medium
5/15/2017	Jefferies Group	Reiterated Rating	Buy	$29.00	N/A
5/15/2017	Deutsche Bank	Boost Price Target	Hold	$25.00 -> $27.00	N/A
4/27/2017	Cleveland Research	Upgrade	Neutral -> Buy		High
3/27/2017	Janney Montgomery Scott	Downgrade	Buy -> Neutral		Low
2/14/2017	Cantor Fitzgerald	Set Price Target	Buy	$28.00	N/A
8/4/2016	UBS	Reiterated Rating	Hold	$27.00	N/A
8/3/2016	Mizuho	Lower Price Target	Neutral	$28.00 -> $23.00	N/A

(Data available from 4/23/2016 forward)

Bruker (NASDAQ:BRKR) Earnings History and Estimates Chart

Earnings by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Earnings Estimates

2018 EPS Consensus Estimate: $1.33
2019 EPS Consensus Estimate: $1.48

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$0.22	$0.30	$0.25
Q2 2018	3	$0.26	$0.32	$0.28
Q3 2018	3	$0.32	$0.34	$0.33
Q4 2018	3	$0.40	$0.56	$0.47
Q1 2019	1	$0.26	$0.26	$0.26
Q2 2019	1	$0.28	$0.28	$0.28
Q3 2019	1	$0.34	$0.34	$0.34
Q4 2019	1	$0.60	$0.60	$0.60

Bruker (NASDAQ BRKR) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/3/2018		$0.25					N/A
2/8/2018	Q4 2017	$0.49	$0.51	$506.74 million	$530.50 million	View	Listen
11/2/2017	Q3 2017	$0.27	$0.29	$415.45 million	$435.60 million	View	N/A
8/3/2017	Q2 2017	$0.20	$0.23	$384.75 million	$414.90 million	View	N/A
5/3/2017	Q1 2017	$0.1870	$0.19	$372.59 million	$384.90 million	View	N/A
2/13/2017	Q416	$0.37	$0.46	$464.49 million	$470.30 million	View	N/A
11/2/2016	Q316	$0.20	$0.32	$394.14 million	$393.90 million	View	N/A
8/2/2016	Q216	$0.20	$0.20	$409.57 million	$371.70 million	View	N/A
5/4/2016	Q116	$0.15	$0.21	$360.37 million	$375.40 million	View	N/A
2/10/2016	Q415	$0.27	$0.38	$469.98 million	$478.20 million	View	N/A
11/4/2015	Q315	$0.13	$0.19	$373.65 million	$396.10 million	View	N/A
8/5/2015	Q215	$0.17	$0.19	$391.87 million	$396.00 million	View	N/A
5/6/2015	Q115	$0.10	$0.14	$369.80 million	$353.50 million	View	N/A
2/19/2015	Q414	$0.29	$0.30	$515.50 million	$508.00 million	View	N/A
11/6/2014	Q314	$0.15	$0.14	$436.30 million	$419.80 million	View	N/A
8/6/2014	Q214	$0.19	$0.21	$457.90 million	$457.40 million	View	N/A
5/7/2014	Q114	$0.09	$0.11	$402.04 million	$423.70 million	View	N/A
2/18/2014	Q413	$0.22	$0.31	$452.14 million	$552.10 million	View	Listen
11/1/2013	Q313	$0.22	$0.20	$452.40 million	$439.00 million	View	Listen
7/31/2013	Q2 2013	$0.14	$0.18	$426.39 million	$454.90 million	View	Listen
5/2/2013	Q1 2013	$0.14	$0.08	$416.76 million	$393.40 million	View	Listen
2/19/2013	Q4 2012	$0.24	$0.28	$483.65 million	$517.30 million	View	Listen
11/5/2012	Q312	$0.15	$0.28	$421.39 million	$447.80 million	View	N/A
7/31/2012		$0.12	$0.12			View	N/A
5/1/2012		$0.12	$0.14			View	N/A
2/22/2012		$0.29	$0.31			View	N/A
10/27/2011		$0.22	$0.23			View	N/A
8/3/2011		$0.21	$0.20			View	N/A
4/28/2011		$0.15	$0.14			View	N/A
2/23/2011		$0.27	$0.27			View	N/A
10/28/2010	Q3 2010	$0.12	$0.19			View	N/A
7/28/2010	Q2 2010	$0.12	$0.15			View	N/A
4/29/2010	Q1 2010	$0.08	$0.10			View	N/A
2/25/2010	Q4 2009	$0.20	$0.27			View	N/A
10/29/2009	Q3 2009	$0.07	$0.10			View	N/A
7/29/2009	Q2 2009	$0.07	$0.08			View	N/A
4/30/2009	Q1 2009	$0.05	$0.05			View	N/A
3/3/2009	Q4 2008	$0.12	$0.18			View	N/A
10/30/2008	Q3 2008	$0.12	$0.11			View	N/A
7/31/2008	Q2 2008	$0.09	$0.13			View	N/A
5/5/2008	Q1 2008	$0.06	$0.05			View	N/A
3/17/2008	Q4 2007	$0.11	$0.26			View	N/A

(Earnings results data provided by Zacks Investment Research)

Bruker (NASDAQ:BRKR) Dividend Information

Bruker pays an annual dividend of $0.16 per share, with a dividend yield of 0.52%. BRKR's most recent quarterly dividend payment was Friday, March 23. Bruker pays out 13.22% of its earnings out as a dividend.

Most Recent Dividend:	3/23/2018
Annual Dividend:	$0.16
Dividend Yield:	0.52%
Payout Ratio:	13.22% (Trailing 12 Months of Earnings) 11.68% (Based on This Year's Estimates) 10.46% (Based on Next Year's Estimates)

Dividend Payments by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ:BRKR) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/20/2018	Quarterly	$0.04	0.51%	3/5/2018	3/6/2018	3/23/2018
11/13/2017	quarterly	$0.04	0.49%	12/1/2017	12/4/2017	12/22/2017
8/14/2017	quarterly	$0.04	0.57%	8/31/2017	9/5/2017	9/22/2017
5/15/2017	quarterly	$0.04	0.61%	6/1/2017	6/5/2017	6/23/2017
2/21/2017	quarterly	$0.04	0.65%	3/6/2017	3/8/2017	3/24/2017
11/15/2016	quarterly	$0.04	0.69%	12/1/2016	12/5/2016	12/23/2016
8/9/2016	quarterly	$0.04	0.72%	9/1/2016	9/6/2016	9/23/2016
5/18/2016	quarterly	$0.04	0.61%	6/2/2016	6/6/2016	6/24/2016
2/22/2016	Quarterly	$0.04		3/2/2016	3/4/2016	3/24/2016

(Data available from 1/1/2013 forward)

Bruker (NASDAQ BRKR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 36.30%
Institutional Ownership Percentage: 65.19%

Insider Trading History for Bruker (NASDAQ:BRKR)

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Bruker (NASDAQ BRKR) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/13/2017	Mark Munch	VP	Sell	21,061	$29.97	$631,198.17	60,524
8/10/2017	Frank H Laukien	CEO	Buy	2,335	$27.39	$63,955.65	37,791,386
6/14/2017	Ingen Chris Van	Director	Sell	19,900	$28.03	$557,797.00	14,577
6/13/2017	Richard Kniss	Director	Sell	24,000	$28.23	$677,520.00	46,753
6/8/2017	Mark Munch	VP	Sell	73,724	$27.62	$2,036,256.88	106,602
5/19/2017	Frank H Laukien	CEO	Buy	3,200	$26.13	$83,616.00	37,789,051
5/18/2017	Frank H Laukien	CEO	Buy	73,000	$26.22	$1,914,060.00	37,750,851
5/16/2017	Frank H Laukien	CEO	Buy	1,920	$25.88	$49,689.60	37,712,851
3/17/2017	Frank H Laukien	CEO	Buy	4,300	$23.34	$100,362.00	37,710,931
3/13/2017	Frank H Laukien	CEO	Buy	2,300	$23.74	$54,602.00	37,706,631
12/15/2016	Frank H Laukien	CEO	Buy	4,725	$21.22	$100,264.50	37,704,331
12/13/2016	Ingen Chris Van	Director	Sell	20,000	$22.29	$445,800.00	5,000
11/25/2016	Frank H Laukien	CEO	Buy	2,124	$22.90	$48,639.60	37,699,606
8/10/2016	Richard A Packer	Director	Buy	10,000	$21.97	$219,700.00	22,500
8/5/2016	Frank H Laukien	CEO	Buy	4,500	$22.17	$99,765.00	37,658,733
6/14/2016	Frank H Laukien	CEO	Buy	4,174	$23.95	$99,967.30	37,654,233
6/6/2016	Joerg C Laukien	Director	Sell	2,000,000	$25.65	$51,300,000.00	15,208,795
5/9/2016	Wolf-Dieter Emmerich	Director	Sell	21,000	$27.35	$574,350.00	3,000
6/15/2015	Frank H Laukien	CEO	Buy	1,000,000	$19.50	$19,500,000.00
6/11/2015	Frank H Laukien	CEO	Buy	5,901	$20.31	$119,849.31
6/11/2015	Stephen W Fesik	Director	Sell	15,000	$20.48	$307,200.00
3/17/2015	Charles F Wagner Jr	CFO	Sell	19,000	$18.97	$360,430.00
3/5/2015	Richard A Packer	Director	Buy	15,000	$19.00	$285,000.00
2/25/2015	Frank H Laukien	CEO	Buy	5,271	$18.95	$99,885.45
12/14/2012	Frank H Laukien	CEO	Buy	50,000	$14.68	$734,000.00

(Data available from 1/1/2013 forward)

Bruker (NASDAQ BRKR) News Headlines

Source:

Date	Headline
	Zacks: Analysts Expect Bruker (BRKR) Will Announce Quarterly Sales of $416.38 Million www.americanbankingnews.com - April 21 at 2:16 AM
	Bruker introduces new workflow-enhancing solutions for microbial identification and antibiotic resistance testing seekingalpha.com - April 20 at 5:36 PM
	Bruker Introduces Bologna Workflow for Rapid and Cost-Effective Clinical Microbiology Diagnosis of Bloodstream Infections with Broad Species Coverage finance.yahoo.com - April 20 at 5:36 PM
	$0.22 EPS Expected for Bruker (BRKR) This Quarter www.americanbankingnews.com - April 19 at 7:20 PM
	Bruker Announces Date and Time of First Quarter 2018 Earnings Release and Webcast finance.yahoo.com - April 19 at 5:56 PM
	Bruker Acquires nanoIR Company Anasys Instruments finance.yahoo.com - April 17 at 6:13 PM
	Bruker (BRKR) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 11 at 10:10 PM
	Morgan Stanley Trims Bruker (BRKR) Target Price to $31.00 www.americanbankingnews.com - April 11 at 9:23 AM
	Bruker introduces the new CTX portable XRF analyzer seekingalpha.com - April 10 at 8:04 AM
	Bruker Introduces the New CTX™ Portable XRF Analyzer finance.yahoo.com - April 10 at 8:04 AM
	Bruker Launches New FT-IR R&D Spectrometer INVENIO™ finance.yahoo.com - April 10 at 8:04 AM
	Coherent (COHR) & Bruker (BRKR) Head-To-Head Survey www.americanbankingnews.com - April 10 at 5:15 AM
	BidaskClub Upgrades Bruker (BRKR) to "Buy" www.americanbankingnews.com - April 6 at 11:17 AM
	Bruker (BRKR) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - April 4 at 9:34 PM
	$419.95 Million in Sales Expected for Bruker (BRKR) This Quarter www.americanbankingnews.com - April 4 at 2:12 AM
	Zacks: Brokerages Anticipate Bruker Co. (BRKR) Will Post Earnings of $0.23 Per Share www.americanbankingnews.com - April 2 at 9:16 PM
	Analyzing Waters (WAT) & Bruker (BRKR) www.americanbankingnews.com - March 31 at 11:21 AM
	Bruker (BRKR) Downgraded by Zacks Investment Research www.americanbankingnews.com - March 30 at 9:28 PM
	Bruker (BRKR) Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - March 29 at 9:36 PM
	Bruker (BRKR) Rating Lowered to Buy at BidaskClub www.americanbankingnews.com - March 28 at 6:32 PM
	Head to Head Analysis: Bruker (BRKR) vs. Allied Motion Technologies (AMOT) www.americanbankingnews.com - March 23 at 5:20 PM
	Critical Contrast: Bruker (BRKR) versus Agilent Technologies (A) www.americanbankingnews.com - March 16 at 1:24 AM
	Bruker Appoints Gerald Herman as Interim Chief Financial Officer finance.yahoo.com - March 14 at 8:03 AM
	Bruker names interim CFO seekingalpha.com - March 14 at 7:43 AM
	Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes finance.yahoo.com - March 12 at 6:55 PM
	Bruker (BRKR) Down 9.3% Since Earnings Report: Can It Rebound? finance.yahoo.com - March 12 at 7:13 AM
	Bruker Co. (BRKR) Receives Consensus Recommendation of "Hold" from Brokerages www.americanbankingnews.com - March 10 at 9:42 PM
	Cerner (CERN) & Bruker (BRKR) Head to Head Survey www.americanbankingnews.com - March 10 at 3:22 PM
	Bruker Corporation to Present at Cowen's 38th Annual Health Care Conference finance.yahoo.com - March 6 at 5:48 PM
	California Public Employees Retirement System Acquires 22,147 Shares of Bruker Co. (BRKR) www.americanbankingnews.com - March 3 at 5:12 AM
	Teacher Retirement System of Texas Buys 28,803 Shares of Bruker Co. (BRKR) www.americanbankingnews.com - March 1 at 5:36 PM
	Bruker Co. (BRKR) Shares Sold by London Co. of Virginia www.americanbankingnews.com - March 1 at 12:34 PM
	Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation finance.yahoo.com - March 1 at 8:00 AM
	$418.40 Million in Sales Expected for Bruker Co. (BRKR) This Quarter www.americanbankingnews.com - March 1 at 3:52 AM
	Zacks: Analysts Expect Bruker Co. (BRKR) Will Announce Earnings of $0.25 Per Share www.americanbankingnews.com - February 27 at 5:18 PM
	Employees Retirement System of Texas Has $2.06 Million Holdings in Bruker Co. (BRKR) www.americanbankingnews.com - February 27 at 12:10 PM
	Bruker Co. (BRKR) Shares Bought by First Trust Advisors LP www.americanbankingnews.com - February 27 at 10:04 AM
	Citadel Advisors LLC Has $2.31 Million Holdings in Bruker Co. (BRKR) www.americanbankingnews.com - February 27 at 5:42 AM
	Systematic Financial Management LP Cuts Stake in Bruker Co. (BRKR) www.americanbankingnews.com - February 26 at 3:52 PM
	Bruker Co. (BRKR) Shares Bought by Fuller & Thaler Asset Management Inc. www.americanbankingnews.com - February 26 at 3:07 PM
	Swiss National Bank Has $6.48 Million Position in Bruker Co. (BRKR) www.americanbankingnews.com - February 26 at 8:20 AM
	Bruker Highlights Innovative Analytical Solutions and Systems at Pittcon finance.yahoo.com - February 26 at 8:01 AM
	Arrowstreet Capital Limited Partnership Acquires 121,410 Shares of Bruker Co. (BRKR) www.americanbankingnews.com - February 26 at 4:46 AM
	Bruker Co. (BRKR) Stake Lessened by OppenheimerFunds Inc. www.americanbankingnews.com - February 24 at 2:56 PM
	Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM finance.yahoo.com - February 22 at 8:02 AM
	Bruker Co. Announces Quarterly Dividend of $0.04 (BRKR) www.americanbankingnews.com - February 21 at 9:56 AM
	Bruker Announces Resignation of Chief Financial Officer and Appointment of Principal Accounting Officer finance.yahoo.com - February 21 at 8:13 AM
	Bruker Co. (BRKR) to Post Q1 2018 Earnings of $0.23 Per Share, William Blair Forecasts www.americanbankingnews.com - February 14 at 8:44 AM
	The Bruker MALDI Biotyper Solution Receives AOAC International Approvals for Two Official Methods of Analysis (OMA) in Food Microbiology finance.yahoo.com - February 14 at 7:51 AM
	Bruker Co. (BRKR) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - February 13 at 9:24 PM

Bruker (NASDAQ:BRKR) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Bruker (NASDAQ:BRKR) Income Statement, Balance Sheet and Cash Flow Statement

Bruker (NASDAQ BRKR) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff